UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care

Clinical cancer research, 2011-04, Vol.17 (7), p.2055-2064

2011

Volltextzugriff (PDF)

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy

BMC cancer, 2012-10, Vol.12 (1), p.482-482, Article 482

2012

Volltextzugriff (PDF)

Zoledronic-Acid-Induced Circulating Level Modifications of Angiogenic Factors, Metalloproteinases and Proinflammatory Cytokines in Metastatic Breast Cancer Patients

Oncology, 2005-01, Vol.69 (1), p.35-43

2005

Volltextzugriff (PDF)

Impact of Five Prophylactic Filgrastim Schedules on Hematologic Toxicity in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide

Journal of clinical oncology, 2005-10, Vol.23 (28), p.6908-6918

2005

Volltextzugriff (PDF)

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

Journal of experimental & clinical cancer research, 2011-05, Vol.30 (1), p.54-54, Article 54

2011

Volltextzugriff (PDF)

Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancer

Expert opinion on pharmacotherapy, 2013-04, Vol.14 (6), p.699-706

2013

Volltextzugriff (PDF)

Is Recurrent Venous Thromboembolism After Therapy Reduced by Low-Molecular-Weight Heparin Compared With Oral Anticoagulants?

Chest, 2006-12, Vol.130 (6), p.1808-1816

2006

Volltextzugriff (PDF)

Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide

Journal of clinical oncology, 2003-09, Vol.21 (18), p.3462-3468

2003

Volltextzugriff (PDF)

Does Granulocyte Colony-Stimulating Factor Worsen Anemia in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide?

Journal of clinical oncology, 2006-07, Vol.24 (19), p.3048-3055

2006

Volltextzugriff (PDF)

Clinical Evaluation of the Use of Exemestane as Further Hormonal Therapy after Nonsteroidal Aromatase Inhibitors in Postmenopausal Metastatic Breast Cancer Patients

Cancer investigation, 2007-01, Vol.25 (2), p.102-105

2007

Volltextzugriff (PDF)

Altered Expression of FAS System Is Related to Adverse Clinical Outcome in Stage I-II Breast Cancer Patients Treated with Adjuvant Anthracycline-Based Chemotherapy

Clinical cancer research, 2004-02, Vol.10 (4), p.1360-1365

2004

Volltextzugriff (PDF)

Taxanes and Gemcitabine Doublets in the Management of HER-2 Negative Metastatic Breast Cancer: Towards Optimization of Association and Schedule

Anticancer research, 2008-03, Vol.28 (2B), p.1245-1258

2008

Volltextzugriff (PDF)

Nanoparticle albumin-bound paclitaxel/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patients

Future oncology (London, England), 2020-08, Vol.16 (22), p.1631-1639

2020

Volltextzugriff (PDF)

HER2/neu role in breast cancer: from a prognostic foe to a predictive friend

Current opinion in obstetrics & gynecology, 2007-02, Vol.19 (1), p.56-62

2007

Volltextzugriff (PDF)

Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development

Future Oncology, 2016-02, Vol.12 (3), p.373-387

2016

Volltextzugriff (PDF)

Nail Disorders in a Woman Treated with Ixabepilone for Metastatic Breast Cancer

Anticancer research, 2005-09, Vol.25 (5), p.3531-3532

2005

Volltextzugriff (PDF)

Acute myeloid leukaemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy

Breast cancer research and treatment, 2008-05, Vol.109 (1), p.187-188

2008

Volltextzugriff (PDF)

Randomized phase II trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer

Breast cancer research and treatment, 2007-03, Vol.101 (3), p.355-365

2007

Volltextzugriff (PDF)

Can the addition of prophylactic filgrastim be considered cost effective in early breast cancer patients treated with epirubicin and cyclophosphamide?

Journal of clinical oncology, 2006-12, Vol.24 (35), p.5615-5616

2006

Volltextzugriff (PDF)

Improved prognosis by trastuzumab of women with HER2-positive breast cancer compared with those with HER2-negative disease

Journal of clinical oncology, 2010-07, Vol.28 (20), p.e337; author reply e338-e337

2010

Volltextzugriff (PDF)

HER2/neu expression and hormonal therapy in early breast cancer: can muddy waters become clear?

Journal of clinical oncology, 2004-02, Vol.22 (3), p.568-569

2004

Volltextzugriff (PDF)

Epirubicin Plus Docetaxel in Metastatic Breast Cancer: Escalating Dose does not Improve Efficacy. A Phase II Study

Anticancer research, 2004-05, Vol.24 (3B), p.1963-1967

2004

Volltextzugriff (PDF)

Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients

Drug design, development and therapy, 2015-01, Vol.9 (default), p.6177-6183

2015

Volltextzugriff (PDF)

Assessment of PTEN and PI3K status in primary breast cancer and corresponding metastases: is it worthwhile?

Journal of clinical oncology, 2011-07, Vol.29 (20), p.2834-2835

2011

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(69)

Sprache

Englisch
(69)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(65)
Life Sciences & Biomedicine
(60)
Science & Technology
(60)
Female
(51)
Oncology
(51)
Breast Neoplasms - Drug Therapy
(47)
Middle Aged
(40)
Adult
(35)
Aged
(34)
Biological And Medical Sciences
(23)
Breast Neoplasms - Pathology
(23)
Medical Sciences
(23)
Breast Cancer
(22)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(21)
Tumors
(21)
Chemotherapy
(20)
Treatment Outcome
(18)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(15)
Drug Administration Schedule
(13)
Gynecology. Andrology. Obstetrics
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy

Zoledronic-Acid-Induced Circulating Level Modifications of Angiogenic Factors, Metalloproteinases and Proinflammatory Cytokines in Metastatic Breast Cancer Patients

Impact of Five Prophylactic Filgrastim Schedules on Hematologic Toxicity in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancer

Is Recurrent Venous Thromboembolism After Therapy Reduced by Low-Molecular-Weight Heparin Compared With Oral Anticoagulants?

Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide

Does Granulocyte Colony-Stimulating Factor Worsen Anemia in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide?

Clinical Evaluation of the Use of Exemestane as Further Hormonal Therapy after Nonsteroidal Aromatase Inhibitors in Postmenopausal Metastatic Breast Cancer Patients

Altered Expression of FAS System Is Related to Adverse Clinical Outcome in Stage I-II Breast Cancer Patients Treated with Adjuvant Anthracycline-Based Chemotherapy

Taxanes and Gemcitabine Doublets in the Management of HER-2 Negative Metastatic Breast Cancer: Towards Optimization of Association and Schedule

Nanoparticle albumin-bound paclitaxel/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patients

HER2/neu role in breast cancer: from a prognostic foe to a predictive friend

Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development

Nail Disorders in a Woman Treated with Ixabepilone for Metastatic Breast Cancer

Acute myeloid leukaemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy

Randomized phase II trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer

Can the addition of prophylactic filgrastim be considered cost effective in early breast cancer patients treated with epirubicin and cyclophosphamide?

Improved prognosis by trastuzumab of women with HER2-positive breast cancer compared with those with HER2-negative disease

HER2/neu expression and hormonal therapy in early breast cancer: can muddy waters become clear?

Epirubicin Plus Docetaxel in Metastatic Breast Cancer: Escalating Dose does not Improve Efficacy. A Phase II Study

Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients

Assessment of PTEN and PI3K status in primary breast cancer and corresponding metastases: is it worthwhile?

Suchergebnisse filtern